The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B.

Erwin GarciaDennis W BennettMargery A ConnellyElias J JeyarajahFranklin C WarfIrina ShalaurovaSteven P MatyusJustyna Wolak-DinsmoreDavid N OskardmayRandolph M YoungMaureen SampsonAlan T RemaleyJames D Otvos

Published in: Lipids in health and disease (2020)

Extensive assay performance evaluations validate that the NMR ELP assay is efficient, robust, and substantially equivalent to standard chemistry assays for the clinical measurement of lipids and apoB. Routine reporting of apoB alongside standard lipid measures could facilitate more widespread utilization of apoB for clinical decision-making.

Keyphrases

high throughput
magnetic resonance
fatty acid
decision making
single cell
emergency department
magnetic resonance imaging
computed tomography
adverse drug
drug discovery
drug induced